| A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1 Y Miki, J Swensen, D Shattuck-Eidens, PA Futreal, K Harshman, ... Science 266 (5182), 66-71, 1994 | 8534 | 1994 |
| A cell cycle regulator potentially involved in genesis of many tumor types A Kamb, NA Gruis, J Weaver-Feldhaus, Q Liu, K Harshman, SV Tavtigian, ... Science 264 (5157), 436-440, 1994 | 4556 | 1994 |
| BRCA1 Mutations in Primary Breast and Ovarian Carcinomas PA Futreal, Q Liu, D Shattuck-Eidens, C Cochran, K Harshman, ... Science 266 (5182), 120-122, 1994 | 1763 | 1994 |
| The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds SV Tavtigian, J Simard, J Rommens, F Couch, D Shattuck-Eidens, ... Nature genetics 12 (3), 333-337, 1996 | 1147 | 1996 |
| Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus A Kamb, D Shattuck-Eidens, R Eeles, Q Liu, NA Gruis, W Ding, C Hussey, ... Nature genetics 8 (1), 22-26, 1994 | 1121 | 1994 |
| Rates of p16 (MTS1) Mutations in Primary Tumors with 9p Loss P Cairns, L Mao, A Merlo, DJ Lee, D Schwab, Y Eby, K Tokino, ... Science 265 (5170), 415-417, 1994 | 657 | 1994 |
| Complex Structure and Regulation of the P16 (MTS1) Locus S Stone, P Jiang, P Dayananth, SV Tavtigian, H Katcher, D Parry, ... Cancer research 55 (14), 2988-2994, 1995 | 577 | 1995 |
| Molecular characterization of Shaker, a Drosophila gene that encodes a potassium channel A Kamb, LE Iverson, MA Tanouye Cell 50 (3), 405-413, 1987 | 570 | 1987 |
| What's wrong with our cancer models? A Kamb Nature reviews Drug discovery 4 (2), 161-165, 2005 | 482 | 2005 |
| Cell-cycle regulators and cancer A Kamb Trends in Genetics 11 (4), 136-140, 1995 | 454 | 1995 |
| Why is cancer drug discovery so difficult? A Kamb, S Wee, C Lengauer Nature reviews Drug discovery 6 (2), 115-120, 2007 | 444 | 2007 |
| Multiple products of the Drosophila Shaker gene may contribute to potassium channel diversity A Kamb, J Tseng-Crank, MA Tanouye Neuron 1 (5), 421-430, 1988 | 382 | 1988 |
| Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds NA Gruis, PA van der Velden, LA Sandkuijl, DE Prins, J Weaver-Feldhaus, ... Nature genetics 10 (3), 351-353, 1995 | 381 | 1995 |
| Methods for measuring relative amounts of nucleic acids in a complex mixture and retrieval of specific sequences therefrom A Kamb, MJ Feldhaus US Patent 6,060,240, 2000 | 292 | 2000 |
| Mass spectrometry to assess DNA sequence polymorphisms A Kamb US Patent 5,869,242, 1999 | 259 | 1999 |
| Green fluorescent protein as a scaffold for intracellular presentation of peptides MR Abedi, G Caponigro, A Kamb Nucleic acids research 26 (2), 623-630, 1998 | 233 | 1998 |
| Low incidence of BRCA2 mutations in breast carcinoma and other cancers DHR Teng, R Bogden, J Mitchell, M Baumgard, R Bell, S Berry, T Davis, ... Nature genetics 13 (2), 241-244, 1996 | 224 | 1996 |
| Genetic evidence in melanoma and bladder cancers that p16 and p53 function in separate pathways of tumor suppression NA Gruis, J Weaver-Feldhaus, Q Liu, C Frye, R Eeles, I Orlow, L Lacombe, ... The American journal of pathology 146 (5), 1199, 1995 | 172 | 1995 |
| Genomic structure, expression and mutational analysis of the P15 (MTS2) gene. S Stone, P Dayananth, P Jiang, JM Weaver-Feldhaus, SV Tavtigian, ... Oncogene 11 (5), 987-991, 1995 | 171 | 1995 |
| Identification of genes from pattern formation, tyrosine kinase, and potassium channel families by DNA amplification. A Kamb, M Weir, B Rudy, H Varmus, C Kenyon Proceedings of the National Academy of Sciences 86 (12), 4372-4376, 1989 | 146 | 1989 |
